| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.02 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.02 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.02 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.03 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |